Schoenherr advised DPx Fine Chemicals Austria, a subsidiary of DPx Holdings BV (www.dpxholdings.com) on the sale of the business divisions Exclusive Synthesis (ES) and Maleic Anhydride Intermediates & Specialties (IM), based in Linz, Austria to the investment firm Ardian France SA, an independent investment company. The transaction was signed on 21 July 2015 and the completion is subject to approval by the antitrust authorities.

IS develops and produces chemical intermediate products for agriculture and other industries. IM produces maleic anhydride, a large number of intermediates, derivatives and esters.

ES and IM generated combined sales of around EUR 200m for the 2014 financial year and have around 390 employees.

The Schoenherr team was led by Christian Herbst and Florian Kusznier (partners, Corporate/M&A). The team also included Maximilian Lang (attorney at law, Corporate/M&A), Tamara Gaggl (attorney at law, Corporate/M&A), Peter Konwitschka (partner, Corporate), Volker Weiss (partner, EU & Competition), Constantin Benes (attorney at law, Real Estate), Franziska Oczlon (associate, Real Estate), Michael Woller (attorney at law, IP), Stefan Kühteubl (partner, Employment), Karolin Andreewitch (associate, Employment), Bernd Rajal (partner, Regulatory) and Mark Tuttinger (associate, Regulatory).